HIV Testing and Life Insurance Underwriting

Texas law allows an insurer to request or require HIV-related testing in connection with an insurance application, but the testing is subject to consent, nondiscrimination, result-notice, confidentiality, and underwriting safeguards. The applicant must be told how the test will be used and give written authorization on a separate form adopted by the commissioner. An agent should treat the test as a sensitive underwriting step: explain the process, obtain the required form before the test, and avoid promises about a decision or the handling of results beyond what the law and insurer say.

Texas permits testing with safeguards

Texas Insurance Code §545.051 authorizes an issuer to request or require an applicant to take an HIV-related test in connection with an application. Authorization does not mean the insurer can test anyone for any reason or use results without limits. The rest of Chapter 545 sets conditions on who may be tested, what the person must be told, how permission is obtained, how a positive result is communicated, and how the information is protected.

Section 545.052 requires testing to be requested or required on a nondiscriminatory basis. An insurer may require a test only if it is based on the applicant’s current medical condition or medical history, or if underwriting guidelines for the coverage amount require testing for all applicants in the risk class. In selecting who is tested, the statute prohibits reliance on marital status, occupation, sex, beneficiary designation, or territorial classification including ZIP code. The question is not whether testing is allowed in general; it is whether the insurer follows the permitted, nondiscriminatory criteria.

That framework allows underwriting to assess risk while limiting arbitrary targeting. A larger amount of coverage may trigger a risk-class testing rule if it applies consistently to the class. A test request based on an individual’s current medical condition or history must still follow the statute and applicable rules. An agent should not decide who deserves testing based on stereotypes, family status, occupation, or a beneficiary’s identity. The insurer’s written underwriting guidelines and current TDI rules control.

Consent must be explicit and separate

Section 545.053 requires an issuer that requests or requires an HIV-related test to explain to the applicant—or another person legally authorized to consent—how the test will be used. The issuer must then obtain that person’s written authorization. The authorization must be on a form adopted by the commissioner and separate from any other document presented to the applicant or authorized person. This is a specific statutory form requirement, not merely a general signature buried in the life application.

TDI lists form LAHR324, Notice and Consent for HIV-Related Testing. A carrier’s current process should use the applicable adopted form and its approved delivery method. The applicant should know the test is being performed in connection with insurance underwriting and how the result may be used. If someone other than the applicant signs, verify that person is legally authorized to consent under applicable law and carrier procedures.

Do not treat a general HIPAA medical-record authorization as interchangeable with the Texas HIV testing consent. HIPAA authorizes certain disclosures of protected health information by covered entities. Chapter 545 governs an insurer’s request or requirement that an applicant take a test. Both may be relevant in one underwriting file, but they address different actions. Obtain each permission required for the particular action and do not assume one signature covers everything.

Consent must be obtained before the requested test is performed. If the proposed insured declines, the agent should not arrange the test as though permission was given. The insurer may be unable to complete underwriting or may make a decision from available information under its rules. Explain the consequence neutrally and let the applicant decide. Never alter or pre-check a consent form, and do not pressure a person to authorize a test without understanding why it is requested.

Questions about past HIV testing

Texas Insurance Code §545.054 allows an issuer to ask whether an applicant has tested positive on an HIV-related test or has been diagnosed with HIV or AIDS. It may not ask whether the applicant has been tested for or received a negative result from a specific test for HIV exposure or a sickness or medical condition derived from HIV infection. That distinction can appear on an exam: a question about a positive result or diagnosis is different from asking whether a negative test was ever taken.

Applicants should answer the exact question asked on the form. They should not omit a diagnosis because they believe a later test was negative, nor should they disclose a negative test if the application asks only a prohibited question about a specific negative result. The agent’s role is to read the carrier question accurately and record the answer, not expand the inquiry beyond what the form and law permit. If a response is unclear, ask underwriting for direction.

This rule should not be confused with a broad guarantee that an insurer can never ask about HIV. Texas permits relevant underwriting questions and testing, subject to the specific statutory restrictions. Nor does a permissible question authorize the agent to make an adverse decision. The insurer must follow underwriting standards, applicable test protocols, and other law.

Positive result: notice and underwriting safeguards

Section 545.055 provides a written-notice process for a positive HIV-related test result. The applicant must be notified by a physician designated by the applicant, or by the Texas Department of State Health Services if the applicant has not designated a physician. The statute authorizes a fee for this notification process. The intent is to route a sensitive result through a designated health professional or the state health department rather than leave it to an insurance agent to deliver casually.

An adverse underwriting decision based on a positive HIV-related test is governed by §545.056 and current test-protocol rules. The insurer cannot treat an unconfirmed screening result as automatically conclusive if the applicable protocol requires further steps. TDI rule amendments concerning §21.705 were proposed in 2026 to update test protocols to current CDC recommendations; TDI’s 2026 rule table still lists that filing as proposed, without an adoption date or effective date. Until an adopted rule is confirmed, the operative statute and current codified rule—not a proposal summary—must guide the exact protocol.

This is a material date-sensitive area. Older published rule text may name testing methods that have since become obsolete, while a proposed rule may announce a planned update without having legal effect. The safe exam and practice statement is that any adverse decision must comply with §545.056 and the currently adopted testing protocol. Do not recite a test sequence from an old form or proposed rule as though it is necessarily the rule in force today.

Confidentiality and record handling

Section 545.057 requires confidentiality of test results. A positive result is not an item an agent should discuss with family members, an employer, a beneficiary, or another producer merely because they are involved in the application. Access should be limited to persons allowed to handle the result under applicable law, the insurer’s underwriting process, and the authorization. Store and transmit information through the insurer’s secure system.

The applicant may designate a physician to receive positive-result notice. That designation does not make the physician the policy owner or authorize unrelated disclosures. The insurer’s underwriters may need information to evaluate the application, but disclosure must follow the statute and current rules. If a client asks who will see a result, the agent should point to the approved notice, authorization, and carrier privacy information rather than improvising a broad assurance.

A privacy breach or misdirected test result should be reported promptly through the insurer’s incident process. Do not try to fix it by deleting messages or asking the recipient to ignore an attachment without following protocol. Proper handling protects the applicant and keeps the insurer’s record accurate. This duty exists alongside HIPAA: Chapter 545 specifically governs insurance testing, while HIPAA controls certain covered entities’ use and disclosure of protected health information.

How this differs from HIPAA

HIPAA usually applies to a covered doctor, clinic, health plan, or clearinghouse. Texas Insurance Code Chapter 545 governs the insurer’s testing practices. A covered physician may need a HIPAA authorization to disclose records to a life insurer; separately, the insurer must obtain the Chapter 545 written consent before requiring an HIV-related test. One concerns a covered entity disclosing existing records; the other concerns insurance testing and use of a test result.

A candidate should identify the actor and action. If the physician is sending records to an underwriter, focus on the disclosure authorization and HIPAA. If the insurer is asking the applicant to undergo an HIV-related test, focus on Chapter 545 consent and nondiscrimination. If the issue is how the result is delivered, check §545.055. If it is who can see it, check §545.057. This actor-action approach prevents confusing adjacent privacy concepts.

Worked examples

Example 1: amount-based testing

A carrier’s approved guidelines require all applicants in a defined high-coverage risk class to complete an HIV-related test. The requirement is applied uniformly to that class. Chapter 545 permits testing under specified underwriting criteria, but the applicant still must receive the required explanation and sign the separate authorization before testing.

Example 2: test selected using a prohibited factor

An insurer chooses applicants for testing based on marital status or the beneficiary named on the application. Section 545.052 prohibits using those characteristics to decide who is requested or required to test. The agent should not participate in or reinforce that selection practice.

Example 3: past negative test question

A form asks whether the applicant ever received a negative result from a specific HIV-exposure test. Chapter 545 prohibits that inquiry. The agent should stop and refer the form to the insurer’s compliance or underwriting team rather than ask the applicant to answer it.

Example 4: positive result

The test result is positive. The insurer follows the statutory notice process through the applicant’s designated physician or DSHS if no physician is designated, maintains confidentiality, and applies the current testing protocol before making any adverse underwriting decision based on the result.

Exam traps

• Saying HIV testing is prohibited for life insurance. Texas permits it subject to safeguards.
• Assuming a general application signature is enough. The written HIV test authorization must be separate and on the adopted form.
• Confusing HIV testing consent with HIPAA authorization for existing medical records.
• Assuming a carrier can test based on any suspicion. The request must meet statutory nondiscrimination criteria.
• Using marital status, occupation, sex, beneficiary, or ZIP code to select applicants for testing.
• Treating a negative-test history question as the same as asking whether the applicant tested positive or has a diagnosis.
• Assuming the agent delivers a positive result. Texas provides a physician or state health department notification route.
• Sharing the result with an employer or family member without authority.
• Treating a screening result as final without following applicable test protocols.
• Quoting a proposed or outdated rule as current. Verify the adopted rule and effective date.

What to remember

Texas permits HIV-related insurance testing only within a protective framework: nondiscriminatory criteria, explanation, separate written authorization, prescribed positive-result notice, confidentiality, and valid test protocols for underwriting decisions. Chapter 545 is the main law. HIPAA may separately govern a provider’s disclosure of medical records. Use current carrier forms and current adopted rules; do not rely on a test result or a proposed rule without confirming the legal process.